More information on all MD Anderson AACR Annual Meeting content can be found at MDAnderson.org/AACR. Targeted small molecule ...

They contribute to crucial processes such as immune evasion, angiogenesis, metabolic reprogramming, and the maintenance of cancer stem ... T cells, and natural killer (NK) cells, is vital for ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 150+ ...

Pilatus Biosciences, a biotechnology company developing immunometabolic therapies for cancer, today announced a preclinical publication in Cancer Discovery detailing the mechanism and therapeutic ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A study in Nature Communications found that older cancer patients have similar outcomes with immune checkpoint inhibitors as ...

Charles River Laboratories International, Inc. , ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has announced updates to its comprehensive portfolio of ...

Cancer vaccines have been a tantalizing idea ... next-generation molecules or drugs from NEO-201, including CAR T/CAR NK cells, T-cell/NK-cell engagers, bispecific antibodies, and antibody-drug ...

NT219, a novel dual inhibitor of IRS1/2 and STAT3, is being evaluated in a Phase 2 study in patients with recurrent and/or ...